These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 38305989)
1. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence. Palma JA Clin Auton Res; 2024 Feb; 34(1):31-44. PubMed ID: 38305989 [TBL] [Abstract][Full Text] [Related]
2. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders. Teal LB; Gould RW; Felts AS; Jones CK Adv Pharmacol; 2019; 86():153-196. PubMed ID: 31378251 [TBL] [Abstract][Full Text] [Related]
3. M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease? Scarpa M; Hesse S; Bradley SJ Adv Pharmacol; 2020; 88():277-310. PubMed ID: 32416870 [TBL] [Abstract][Full Text] [Related]
4. Effects of central muscarinic-1 receptor stimulation on blood pressure regulation. Medina A; Bodick N; Goldberger AL; Mac Mahon M; Lipsitz LA Hypertension; 1997 Mar; 29(3):828-34. PubMed ID: 9052903 [TBL] [Abstract][Full Text] [Related]
5. Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review. Vaidya S; Guerin AA; Walker LC; Lawrence AJ CNS Drugs; 2022 Nov; 36(11):1171-1206. PubMed ID: 36269510 [TBL] [Abstract][Full Text] [Related]
6. [Muscarinic M1 and/or M4 receptor agonists as potential novel treatments for psychoses]. Spoelstra SK; Visser L; Knegtering H Tijdschr Psychiatr; 2023; 65(9):555-562. PubMed ID: 37947466 [TBL] [Abstract][Full Text] [Related]
7. Opportunities and challenges for the development of M Nguyen HTM; van der Westhuizen ET; Langmead CJ; Tobin AB; Sexton PM; Christopoulos A; Valant C Br J Pharmacol; 2024 Jul; 181(14):2114-2142. PubMed ID: 36355830 [TBL] [Abstract][Full Text] [Related]